Literature DB >> 16970569

Transfer of the antidepressant mirtazapine into breast milk.

J H Kristensen1, Kenneth F Ilett, Jonathan Rampono, Rolland Kohan, L Peter Hackett.   

Abstract

AIMS: To investigate the transfer of mirtazapine and desmethylmirtazapine into milk and to calculate dose to the infant via milk.
METHODS: Plasma and milk samples were obtained from eight breast-feeding women who were taking a median dose of 38 mg mirtazapine per day. Milk/plasma ratio (M/P) and infant doses were estimated by standard methods. The infants were examined clinically and in four infants blood was taken for analysis.
RESULTS: Mean (95% confidence interval) relative infant doses for mirtazapine and desmethylmirtazapine (n = 8) were 1.5% (0.8, 2.2) and 0.4% (0.2, 0.6) respectively. The mean M/P (area under curve n = 4, single or paired samples n = 3) was 1.1 (0.7,1.5) for mirtazapine and 0.6 (0.5, 0.7) for desmethylmirtazapine. No adverse effects were seen. Mirtazapine was detected (1.5 microg l(-1)) in only one of four infants tested.
CONCLUSION: We suggest that mirtazapine use by lactating women is safe for the breast-fed infant. Nevertheless, each decision to breast feed should always be made on the basis of an individual risk/benefit analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970569      PMCID: PMC2000733          DOI: 10.1111/j.1365-2125.2006.02773.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Mirtazapine and breast-feeding.

Authors:  Wolfgang Aichhorn; Alexandra B Whitworth; Ulrike Weiss; Christoph Stuppaeck
Journal:  Am J Psychiatry       Date:  2004-12       Impact factor: 18.112

Review 2.  The medical management of depression.

Authors:  J John Mann
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

3.  The use of developmental screening and assessment instruments by paediatricians in Australia.

Authors:  E J Rossiter
Journal:  J Paediatr Child Health       Date:  1993-10       Impact factor: 1.954

Review 4.  An overview of the clinical efficacy of mirtazapine.

Authors:  O Benkert; M Muller; A Szegedi
Journal:  Hum Psychopharmacol       Date:  2002-06       Impact factor: 1.672

5.  Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

Authors:  J D Guelfi; M Ansseau; L Timmerman; S Kørsgaard
Journal:  J Clin Psychopharmacol       Date:  2001-08       Impact factor: 3.153

6.  Creamatocrit: simple clinical technique for estimating fat concentration and energy value of human milk.

Authors:  A Lucas; J A Gibbs; R L Lyster; J D Baum
Journal:  Br Med J       Date:  1978-04-22

Review 7.  Clinical pharmacokinetics of mirtazapine.

Authors:  C J Timmer; J M Sitsen; L P Delbressine
Journal:  Clin Pharmacokinet       Date:  2000-06       Impact factor: 6.447

Review 8.  Studying drugs in human milk: time to unify the approach.

Authors:  Evan J Begg; Stephen B Duffull; L Peter Hackett; Kenneth F Ilett
Journal:  J Hum Lact       Date:  2002-11       Impact factor: 2.219

9.  Adjustment of children of depressed mothers: a 10-month follow-up.

Authors:  C M Lee; I H Gotlib
Journal:  J Abnorm Psychol       Date:  1991-11

10.  Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women.

Authors:  M W O'Hara; E M Zekoski; L H Philipps; E J Wright
Journal:  J Abnorm Psychol       Date:  1990-02
View more
  16 in total

Review 1.  Depression in childbearing women: when depression complicates pregnancy.

Authors:  Sheila M Marcus; Julie E Heringhausen
Journal:  Prim Care       Date:  2009-03       Impact factor: 2.907

Review 2.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

Review 3.  The impact of mood disorders and their treatment on the pregnant woman, the fetus, and the infant.

Authors:  Angelica L Kloos; Abigail Dubin-Rhodin; Jillan Cantor Sackett; Thomas A Dixon; Ronald A Weller; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

Review 4.  Depression During Pregnancy and Postpartum.

Authors:  Madeleine Becker; Tal Weinberger; Ann Chandy; Sarah Schmukler
Journal:  Curr Psychiatry Rep       Date:  2016-03       Impact factor: 5.285

Review 5.  Antidepressant use during pregnancy: current controversies and treatment strategies.

Authors:  Jennifer L Payne; Samantha Meltzer-Brody
Journal:  Clin Obstet Gynecol       Date:  2009-09       Impact factor: 2.190

Review 6.  Antidepressant medication use during breastfeeding.

Authors:  Teresa Lanza di Scalea; Katherine L Wisner
Journal:  Clin Obstet Gynecol       Date:  2009-09       Impact factor: 2.190

7.  When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care.

Authors:  Maria Muzik; Sheila M Marcus; Julie E Heringhausen; Heather Flynn
Journal:  Obstet Gynecol Clin North Am       Date:  2009-12       Impact factor: 2.844

Review 8.  Mirtazapine: a review of its use in major depression and other psychiatric disorders.

Authors:  Katherine F Croom; Caroline M Perry; Greg L Plosker
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 9.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

10.  More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.

Authors:  Geetha Desai; Girish N Babu; Ravi P Rajkumar; Prabha S Chandra
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.